Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role

Area of Science:

• Oncology
• Pharmacology

Background:

• Lung cancer is a prevalent malignancy often managed with chemotherapy, radiotherapy, or surgery.
• Emerging research suggests certain drugs, like statins, may offer therapeutic benefits in cancer treatment.
• Statins inhibit hydroxy-3-methylglutaryl-coenzyme A reductase, impacting genes crucial to lung cancer development.

Purpose of the Study:

• To review experimental and clinical studies on statins' effects in lung cancer.
• To assess the efficacy and safety of statins for lung cancer.
• To explore gender-specific responses and personalized therapy via mevalonate pathway modulation.

Main Methods:

• Narrative review of existing literature.
• Analysis of studies investigating statins in lung cancer models and patients.
• Evaluation of data on statin effectiveness, safety, and gender differences.

Main Results:

• Statins demonstrate pleiotropic effects on genes involved in lung cancer pathogenesis.
• Experimental and clinical data suggest potential benefits of statins in lung cancer.
• Evidence regarding the clinical utility and safety of statins in lung cancer treatment remains limited.

Conclusions:

• Statins exhibit multifaceted impacts on lung cancer cells.
• Further clinical validation is required to establish statins as a standard lung cancer therapy.
• Personalized treatment strategies may emerge from understanding gender differences and mevalonate pathway modulation.